Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fat-soluble vitamin status in patients on long-term octreotide
NL-OMON24514Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label trial of octreotide in acromegaly and Carcinoid Tumor (CT) (2 cohorts), sponsored by University Medical Center Groningen. Primary endpoints: Fat-soluble vitamin levels, Relevant lipid components and 1 more. Started Jan 2009; status: recruiting.
02
Drugs
octreotide
03
Conditions
acromegalyCarcinoid Tumor (CT)
Beyond the preview
Go deeper on NL-OMON24514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24514.